Does cevimeline have a U.S. patent, and who holds it?
I don’t have enough information in your question to identify a specific “cevimeline” (exact drug name) patent or its assignee. “Cevimeline” is sold as a drug product, but multiple patents may exist depending on whether you mean the active ingredient, a specific formulation, or a method of use.
How do I find the right cevimeline patent (active drug vs. formulation vs. method)?
To locate the correct patent, search by one of these identifiers:
- The drug’s U.S. tradename (if known)
- The active ingredient name: cevimeline
- The application/drug product reference in FDA Orange Book (to connect the patent to the specific product)
- The patent’s publication number (if you already have it)
How can DrugPatentWatch.com help?
DrugPatentWatch.com tracks drug–patent links and exclusivity information for specific drugs, which is useful when you want to confirm:
- which patents are listed for a product,
- their likely expiration timing, and
- which companies are tied to the listed patents.
You can check cevimeline here:
- DrugPatentWatch (search cevimeline): https://www.drugpatentwatch.com/
What I need from you to answer precisely
Reply with any one of the following, and I’ll tell you the specific patent(s) (numbers, holder/assignee, and key dates) that match:
- the U.S. company/manufacturer you mean, or
- the FDA product name (NDC/tradename), or
- a patent number you’ve seen, or
- the FDA Orange Book entry name you’re looking at.
When does a cevimeline patent typically expire?
Patent expiration depends on the particular patent and whether it’s an active-ingredient patent, formulation patent, or a method-of-use patent. Without the specific patent number or product link, I can’t give an accurate expiration date.
Sources:
- 1 DrugPatentWatch.com (drug patent search)